Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study

J Photochem Photobiol B. 2016 Jan:154:34-9. doi: 10.1016/j.jphotobiol.2015.11.009. Epub 2015 Nov 30.

Abstract

Background: Photodynamic therapy (PDT) delays ultraviolet (UV) radiation-induced squamous cell carcinomas (SCCs) in hairless mice. Efficacy may be enhanced by combining PDT with antineoplastic or pro-differentiating agents. We investigated if pretreatment with 5-fluorouracil (5FU), imiquimod (IMIQ) or calcipotriol (CAL) before PDT further delays tumor onset.

Methods: Hairless mice (n=224) were exposed 3 times weekly to 3 standard erythema doses (SED) of UV radiation. Methyl-aminolevulinate (MAL)-PDT sessions were given on days 45 and 90 before SCC development. Three applications of topical 5FU, IMIQ or CAL were given before each PDT session. Fluorescence photography quantified protoporphyrin IX (PpIX) formation.

Results: PDT delayed UV-induced SCC development by 59 days (212 days UV-MAL-PDT vs. 153 days UV-control, P<0.001). Pretreatment with 5FU, IMIQ or CAL before PDT did not further delay SCC onset compared to PDT alone (207 days UV-5FU-MAL-PDT, 215 days UV-IMIQ-MAL-PDT, 206 days UV-CAL-MAL-PDT vs. 212 days UV-MAL-PDT, P=ns). PpIX fluorescence intensified by 5FU-pretreatment (median 21,392 au UV-5FU-MAL-PDT, P=0.011), decreased after IMIQ-pretreatment (12,452 au UV-IMIQ-MAL-PDT, P<0.001), and was unaffected by CAL-pretreatment (19,567 au UV-CAL-MAL-PDT, P=ns) compared to MAL alone (18,083 au UV-MAL-PDT).

Conclusions: Short-term three-day pretreatment with 5FU, IMIQ and CAL before PDT does not further delay tumor onset in UV-exposed hairless mice.

Keywords: Antineoplastic drugs; Hairless mice; Photodynamic therapy; Pretreatment; Protoporphyrin IX.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminolevulinic Acid / analogs & derivatives
  • Aminolevulinic Acid / pharmacology
  • Aminolevulinic Acid / therapeutic use
  • Aminoquinolines / therapeutic use
  • Animals
  • Calcitriol / analogs & derivatives
  • Calcitriol / therapeutic use
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / etiology
  • Carcinoma, Squamous Cell / prevention & control
  • Female
  • Fluorouracil / therapeutic use
  • Imiquimod
  • Mice
  • Mice, Hairless
  • Photochemotherapy
  • Photosensitizing Agents / therapeutic use
  • Protoporphyrins
  • Skin / drug effects
  • Skin / radiation effects
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / etiology
  • Skin Neoplasms / prevention & control
  • Ultraviolet Rays*

Substances

  • Aminoquinolines
  • Photosensitizing Agents
  • Protoporphyrins
  • calcipotriene
  • methyl 5-aminolevulinate
  • Aminolevulinic Acid
  • protoporphyrin IX
  • Calcitriol
  • Imiquimod
  • Fluorouracil